BiomedycynaPolska S. A. is at the helm of a corporate group of Polish biotechnological companies that specialize in and develop technologies for separation and purification of active pharmaceutical ingredients (API), veterinary medicines as well as dietary supplements. Thanks to holding 100% of the shares of the other group members, the company can offer an integrated business model, starting from development of new technologies, encompassing the entire development path and ending with sale of the product, including proprietary medicinal products. Biomedycyna Polska S. A. invests into development of innovative pharmaceuticals and APIs for treatment and prevention of the main lifestyle diseases e.g. immune system disorders, autoimmunological diseases, communicable diseases and cancers. Biomedycyna Polska S. A. maintains a strong research and development division, which allows for creation of brand-new solutions in the form of applications for innovative API production processes and innovative product solutions.
Headquarters
Ul. Muchoborska 6
Wroclaw; Dolnoslaskie;
Postal Code: 54-424
Contact Details: Purchase the Biomedycyna Polska S.A. report to view the information.
Website: http://www.biomedycynapolska.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service